Patent · US Expired

Epidermal growth factor receptor antibodies

US6129915A · kind A · utility

20Cited by
0References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 23, 1999
Grant dateOct 10, 2000
Priority date
Expiry dateApr 23, 2019

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention is related to single and double chain antibodies to EGF receptor. The invention also relates to toxin conjugates of such antibodies. These antibodies are useful for treating and diagnosing the status of pathological conditions such as cancer and cellular hyper proliferation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.